[1] |
Locker GY. Hormonal therapy of breast cancer [J]. Cancer Treat Rev,1998,24(3):221-240.
|
[2] |
徐兵河. 乳腺癌内分泌治疗的现状与展望[J].中华肿瘤防治杂志,2005,13(3):161-163.
|
[3] |
谢国柱,詹军芳,孙爱民,等. 辐射与悬浮球培养联合纯化乳腺癌干细胞[J]. 实用医学杂志.2010,26(11):1893-1896.
|
[4] |
杨向茹,李西秦,马敏,等. 基质金属蛋白酶及其抑制剂和转化生长因子-β1 在中耳胆脂瘤的表达[J].中华耳鼻咽喉科杂志,2002,37(2):121-123.
|
[5] |
Levina V, Marrangoni AM, DeMarco R, et al. Drug-selected human lung cancer stem cells: cytokine network,tumorigenic and metastatic properties [J]. PLoS One,2008,3(8):3077.
|
[6] |
肖锡岗,房林. 乳腺肿瘤干细胞筛选方法和治疗抵抗研究进展[J/CD]. 中华乳腺病杂志:电子版,2010,4(3):329-338.
|
[7] |
王佳妮,刘仁斌,梁惠珍, 等. 乳腺癌组织中HER2、ERα、ERβ、PR 的表达及其相关性分析[J/CD]. 中华普通外科学文献: 电子版,2008,2(6):34-37.
|
[8] |
江泽飞,宋三泰. 乳腺癌内分泌治疗的新思路和新策略[J].中华肿瘤杂志,2003,25(4):410-411.
|
[9] |
郑璐玉,张旭. 肿瘤干细胞的研究进展[J].现代肿瘤医学,2009,17(5):959-961.
|
[10] |
Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci USA,2003,100(7):3983-3988
|
[11] |
Sheridan C, Kishimoto H, Fuchs RK, et al. CD44+/CD24-breast cancer cells exhibit enhanced in properties: an early step necessary for metastasis [J].Breast Cancer Res,2006,8(5):R59.
|
[12] |
Ponti D, Costa A, Zaffaroni N, et al.Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties [J].Cancer Res,2005,65 (13):5506-5511
|
[13] |
Shipitsin M,Campbell LL,Argani P,et al. Molecular definition of breast tumor heterogeneity [J]. Cancer Cell,2007, 11(3):259-273.
|
[14] |
谢竞,周艳,唐鹏, 等. 克隆柱法提取MCF-7 乳腺癌细胞系中癌干细胞[J/CD]. 中华乳腺病杂志:电子版, 2009,3(2):187-194.
|
[15] |
孙红梅. 乳腺癌细胞MCF-7 和MDA-MB-231 CD44+/CD24-/low 细胞亚群对血管生成影响的研究[D]. 北京:北京大学临床肿瘤学院,2009.
|
[16] |
陈健,陈增良. 乳腺癌干细胞的分选鉴定[J]. 癌症,2010,29(3):284-289.
|